Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

Dr. Edelman shares 10 key strategies for type 1 diabetics to manage blood glucose levels, including CGM tips, diet, and exercise, at ATTD.
For adults with type 1 diabetes, the adoption of automated insulin delivery systems can be life-changing. Emerging research shows the same benefits extend to children...
While AID has traditionally been used in type 1 diabetes, new data suggests this technology has many of the same benefits in type 2 – namely, improving time in range and...
Riva Greenberg, who has lived with type 1 diabetes for over 50 years, explains how managing blood sugar – rather than trying to control it – has improved her time in...
Learn to prevent CGM skin irritation with tips on sensor placement, hygiene, and helpful products for comfortable diabetes management.
UVA’s PEDAP-AI trial now recruiting for AI-assisted insulin pump settings in kids with type 1 diabetes ages 2-5 using Tandem pump and Dexcom CGM systems.
Tandem’s Mobi automated insulin delivery system has officially launched in the U.S. The world’s smallest insulin delivery system to be fully controlled by a smartphone...
A1C, crucial for diabetes management, varies by race, affecting accuracy. Supplementary measures like TIR offer a more tailored approach.
Discover the advances in diabetes care, from urine tests to CGM technology, enhancing management and quality of life for those with diabetes.
Explore strategies for managing post-meal blood sugar spikes in diabetes, including adjusting insulin doses, dietary changes, and physical activity. Learn the importance...
Exploring the guilt linked to high blood sugars, this article addresses the emotional toll of diabetes data and emphasizes detaching self-worth from numbers.
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
Discover how automated insulin delivery (AID) benefits type 1 diabetes and ongoing trials assessing the impact of AID systems on type 2 diabetes management.
Exploring the "diabetes superhero" meme, diaTribe’s Diane Scherer reflects on 40 years of living with diabetes, revealing the dichotomies of bravery, strength, and hope.
Omnipod 5 users will soon be able to control their AID system through a free iPhone app available in the new year. Like the Android app, iPhone users will be able to...
Researchers find automated insulin delivery (AID) systems, the MiniMed 780G and Omnipod 5, showed significant improvement in time in range for everyday users. This real-...
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
Lauren Bongiorno, a diabetes coach and person living with type 1 diabetes, shares her top strategies for managing diabetes while traveling or stepping outside your daily...

Pages